✦ LIBER ✦

Pathological complete response and survival according to the level of HER-2 amplification after trastuzumab-based neoadjuvant therapy for breast cancer

✍ Scribed by Guiu, S; Gauthier, M; Coudert, B; Bonnetain, F; Favier, L; Ladoire, S; Tixier, H; Guiu, B; Penault-Llorca, F; Ettore, F

Book ID: 110000718
Publisher: Nature Publishing Group
Year: 2010
Tongue: English
Weight: 413 KB
Volume: 103
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6605939

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of ER, PgR, HER-2, Ki-67, cyc

Evaluation of ER, PgR, HER-2, Ki-67, cyclin D1, and nm23-H1 as predictors of pathological complete response to neoadjuvant chemotherapy for locally advanced breast cancer

✍ Xi-ru Li; Mei Liu; Yan-jun Zhang; Jian-dong Wang; Yi-qiong Zheng; Jie Li; Bing M 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 425 KB

ER, PgR, HER-2, Ki-67, topoisomerase IIα

ER, PgR, HER-2, Ki-67, topoisomerase IIα, and nm23-H1 proteins expression as predictors of pathological complete response to neoadjuvant chemotherapy for locally advanced breast cancer

✍ Xi-ru Li; Mei Liu; Yan-jun Zhang; Jian-dong Wang; Yi-qiong Zheng; Jie Li; Bing M 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 396 KB

Risk of cerebral metastases and neurolog

Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung cancer : Clinical implications for the subsequent management of the brain

✍ Allen M. Chen; Thierry M. Jahan; David M. Jablons; Joaquin Garcia; David A. Lars 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

## Abstract ## BACKGROUND. The incidence and pattern of brain metastases was analyzed among patients who achieved a pathological complete response (pCR) after neoadjuvant chemotherapy or chemoradiotherapy for locally advanced nonsmall‐cell lung cancer (NSCLC). ## METHODS. Between 1990 and 2004,